Jenny Huizing

Papers

Total Citations

H-Index

About

Jenny Huizing is a rising leader in the intersection of developmental biology and biomedical engineering, with a primary focus on automating high-throughput *in vivo* models for cancer research. Her key contributions center on the zebrafish xenograft model, a powerful tool for predicting patient-specific responses to cancer therapeutics. Recognizing that the manual microinjection of cancer cells into fragile zebrafish larvae is a critical bottleneck—requiring extensive training and limiting clinical scalability—Huizing has pioneered automated microinjection systems. Her most cited work (2025, 5 citations) and a related study (2024, 2 citations) detail the development of precise, robotic platforms that dramatically increase throughput and reproducibility. This innovation is pivotal for translating zebrafish xenografts from a research tool into a practical clinical diagnostic. By automating a laborious, high-skill task, Huizing’s research directly addresses a major barrier to personalized medicine, enabling faster, more reliable drug screening. Her work is already recognized for its potential to standardize and accelerate cancer treatment decisions, marking her as a key innovator in the field of automated *in vivo* diagnostics.